Author

Fabiana Castiglione

WERNICKE'S ENCEPHALOPATHY IN ULCERATIVE COLITIS
WERNICKE'S ENCEPHALOPATHY IN ULCERATIVE COLITIS

DEEP REMISSION IN CROHN’S DISEASE ON BIOLOGIC THERAPY: TOWARDS A NEW DEFINITION
DEEP REMISSION IN CROHN’S DISEASE ON BIOLOGIC THERAPY: TOWARDS A NEW DEFINITION

Fabiana Castiglione  et al.

DEEP REMISSION IN CROHN'S DISEASE ON BIOLOGIC THERAPY: TOWARDS A NEW DEFINITION
DEEP REMISSION IN CROHN'S DISEASE ON BIOLOGIC THERAPY: TOWARDS A NEW DEFINITION

EARLY ULTRASOUND ASSESSMENT PREDICTS THERAPY RESPONSE: AN EASYTOOL FOR CLINICAL DECISION MAKING
EARLY ULTRASOUND ASSESSMENT PREDICTS THERAPY RESPONSE: AN EASYTOOL FOR CLINICAL DECISION MAKING

Fabiana Castiglione  et al.

SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)
SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)

Fabiana Castiglione  et al.

REDUCED HUMORAL RESPONSE TO TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE-IBD, AN IG-IBD STUDY
REDUCED HUMORAL RESPONSE TO TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE-IBD, AN IG-IBD STUDY

Fabiana Castiglione  et al.

ASSESSMENT OF SARCOPENIA AND NUTRITIONAL STATUS IN A COHORT OF PATIENTS WITH CROHN’S DISEASE
ASSESSMENT OF SARCOPENIA AND NUTRITIONAL STATUS IN A COHORT OF PATIENTS WITH CROHN’S DISEASE

Fabiana Castiglione  et al.

EFFECTIVENESS OF PARTIAL ENTERAL NUTRITION TO TREAT ADULTS WITH CROHN’S DISEASE WHO LOST RESPONSE TO BIOLOGICAL THERAPY
EFFECTIVENESS OF PARTIAL ENTERAL NUTRITION TO TREAT ADULTS WITH CROHN’S DISEASE WHO LOST RESPONSE TO BIOLOGICAL THERAPY

Fabiana Castiglione  et al.

WERNICKE’S ENCEPHALOPATHY IN ULCERATIVE COLITIS
WERNICKE’S ENCEPHALOPATHY IN ULCERATIVE COLITIS

Fabiana Castiglione  et al.

THE IMPACT OF A DEDICATED INFLAMMATORY BOWEL DISEASE CONTACT CENTER ON CLINICAL OUTCOME OF PATIENTS DURING THE COVID 19 OUTBREAK
THE IMPACT OF A DEDICATED INFLAMMATORY BOWEL DISEASE CONTACT CENTER ON CLINICAL OUTCOME OF PATIENTS DURING THE COVID 19 OUTBREAK

Fabiana Castiglione  et al.

REDUCING DIAGNOSTIC DELAY OF EXTRA-INTESTINAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A COMPARATIVE STUDY OF A MULTIDISCIPILINARY IMMUNE-MEDIATED DISEASES OUTPATIENT CLINIC AND CONVENTIONAL REFERRAL SPECIALISTS
REDUCING DIAGNOSTIC DELAY OF EXTRA-INTESTINAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A COMPARATIVE STUDY OF A MULTIDISCIPILINARY IMMUNE-MEDIATED DISEASES OUTPATIENT CLINIC AND CONVENTIONAL REFERRAL SPECIALISTS

Fabiana Castiglione  et al.

EFFECT OF TRANSITION CARE ON CLINICAL OUTCOMES AND TREATMENT ADHERENCE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: AN OBSERVATIONAL PROSPECTIVE STUDY
EFFECT OF TRANSITION CARE ON CLINICAL OUTCOMES AND TREATMENT ADHERENCE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: AN OBSERVATIONAL PROSPECTIVE STUDY

Fabiana Castiglione  et al.

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

Fabiana Castiglione  et al.

TREATMENT-BASED RISK STRATIFICATION OF INFECTIONS IN INFLAMMATORY BOWEL DISEASE: A COMPARISON BETWEEN ANTI-TNF? AND NON-BIOLOGIC EXPOSURE IN REAL WORLD SETTING
TREATMENT-BASED RISK STRATIFICATION OF INFECTIONS IN INFLAMMATORY BOWEL DISEASE: A COMPARISON BETWEEN ANTI-TNF? AND NON-BIOLOGIC EXPOSURE IN REAL WORLD SETTING

Fabiana Castiglione  et al.

USTEKINUMAB IS SUPERIOR IN TREATMENT PERSISTENCE AND COLECTOMY-FREE SURVIVAL AMONG SEQUENTIAL BIOLOGICAL THERAPIES IN MODERATE-TO-SEVERE ULCERATIVE COLITIS REFRACTORY TO ANTI-TNF – PRELIMINARY DATA OF A RETROSPECTIVE, MULTICENTRE STUDY
USTEKINUMAB IS SUPERIOR IN TREATMENT PERSISTENCE AND COLECTOMY-FREE SURVIVAL AMONG SEQUENTIAL BIOLOGICAL THERAPIES IN MODERATE-TO-SEVERE ULCERATIVE COLITIS REFRACTORY TO ANTI-TNF – PRELIMINARY DATA OF A RETROSPECTIVE, MULTICENTRE STUDY

Fabiana Castiglione  et al.

USTEKINUMAB IS SUPERIOR IN TREATMENT PERSISTENCE AND COLECTOMY-FREE SURVIVAL AMONG SEQUENTIAL BIOLOGICAL THERAPIES IN MODERATE-TO-SEVERE ULCERATIVE COLITIS REFRACTORY TO ANTI-TNF – PRELIMINARY DATA OF A RETROSPECTIVE, MULTICENTRE STUDY
USTEKINUMAB IS SUPERIOR IN TREATMENT PERSISTENCE AND COLECTOMY-FREE SURVIVAL AMONG SEQUENTIAL BIOLOGICAL THERAPIES IN MODERATE-TO-SEVERE ULCERATIVE COLITIS REFRACTORY TO ANTI-TNF – PRELIMINARY DATA OF A RETROSPECTIVE, MULTICENTRE STUDY

Fabiana Castiglione  et al.

ULTRASONOGRAPHY TIGHT CONTROL AND MONITORING IN CROHN'S DISEASE DURING DIFFERENT BIOLOGICAL THERAPIES: A MULTICENTER STUDY
ULTRASONOGRAPHY TIGHT CONTROL AND MONITORING IN CROHN'S DISEASE DURING DIFFERENT BIOLOGICAL THERAPIES: A MULTICENTER STUDY

Fabiana Castiglione  et al.

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects

Fabiana Castiglione  et al.

Item 1 - 18 / 18
1